2018年12月
[Global Trends Survey for Targeted Radionuclide Therapy].
Nihon Hoshasen Gijutsu Gakkai zasshi
- ,
- ,
- ,
- ,
- ,
- ,
- 巻
- 74
- 号
- 12
- 開始ページ
- 1443
- 終了ページ
- 1448
- 記述言語
- 日本語
- 掲載種別
- 研究論文(学術雑誌)
- DOI
- 10.6009/jjrt.2018_JSRT_74.12.1443
Radionuclide therapy has been used to help manage a range of diseases and has a role of growing importance, with an increasing impact on clinical practice globally. A survey in the field of Radionuclide therapy was conducted by reviewing 4199 science abstracts of main conference (Japanese Society of Radiological Technology, Japanese Society of Nuclear Medicine, Japanese Society of Nuclear Medicine Technology, Society of Nuclear Medicine and Molecular Imaging, European Association of Nuclear Medicine) held in 2016. This survey consisted of research content, modality for evaluation, dosimetry, radionuclide, and researcher's country. There tend to be a lot of studies related to targeted radionuclide therapy more than Japan (4%) in the United States (11%) or Europe (13%). Radiopharmaceuticals still un-approving in Japan were used in some of these studies. And many studies on dosimetry using PET or SPECT imaging were confirmed in the United States (37%) or in Europe (25%) compared with in Japan (14%). This survey has clarified the current status of Japan and global trend in the field of radionuclide therapy.
- リンク情報
- ID情報
-
- DOI : 10.6009/jjrt.2018_JSRT_74.12.1443
- ISSN : 0369-4305
- PubMed ID : 30568095